FDA Strategic Plan: Outsourcing Reviews For One-Third Of FTEs By 2006
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to complete reviews of competitive outsourcing opportunities for certain accounting and clerical services by the end of fiscal year 2004
You may also be interested in...
FDA Hormone Therapy Education Campaign Affirms Osteoporosis Use
FDA is not taking a position on the combination of "natural" products used in conjunction with hormone therapy in its consumer education campaign on hormone therapy launched Sept. 9
FDA Hormone Therapy Education Campaign Affirms Osteoporosis Use
FDA is not taking a position on the combination of "natural" products used in conjunction with hormone therapy in its consumer education campaign on hormone therapy launched Sept. 9
FDA Hormone Therapy Education Campaign Affirms Osteoporosis Use
FDA is not taking a position on the combination of "natural" products used in conjunction with hormone therapy in its consumer education campaign on hormone therapy launched Sept. 9